The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene label mismatch: NEB vs undefined
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_001164508.2(NEB):c.1493A>G (p.Asp498Gly)

CA348825220

533979 (ClinVar)

Gene: NEB
Condition: nemaline myopathy
Inheritance Mode: Autosomal recessive inheritance
UUID: 79266f92-7df8-40de-be2e-c648de9e1355
Approved on: 2025-03-10
Published on: 2025-03-27

HGVS expressions

NM_001164508.2:c.1493A>G
NM_001164508.2(NEB):c.1493A>G (p.Asp498Gly)
NC_000002.12:g.151696713T>C
CM000664.2:g.151696713T>C
NC_000002.11:g.152553227T>C
CM000664.1:g.152553227T>C
NC_000002.10:g.152261473T>C
NG_009382.2:g.42775A>G
ENST00000397345.8:c.1493A>G
ENST00000427231.7:c.1493A>G
ENST00000172853.14:c.1493A>G
ENST00000397345.7:c.1493A>G
ENST00000409198.5:c.1493A>G
ENST00000427231.6:c.1493A>G
ENST00000489048.1:n.392A>G
ENST00000603639.5:c.1493A>G
ENST00000604864.5:c.1493A>G
ENST00000618972.4:c.1493A>G
NM_001164507.1:c.1493A>G
NM_001164508.1:c.1493A>G
NM_001271208.1:c.1493A>G
NM_004543.4:c.1493A>G
NM_001271208.2:c.1493A>G
NM_004543.5:c.1493A>G
NM_001164507.2:c.1493A>G
More

Likely Pathogenic

Met criteria codes 3
PM3_Strong PP4 PM2_Supporting
Not Met criteria codes 23
PS2 PS4 PS3 PS1 BP5 BP7 BP2 BP4 BP1 BP3 PP1 PP3 PP2 PM1 PM5 PM4 PM6 BA1 BS2 BS4 BS3 BS1 PVS1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Congenital Myopathies Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for NEB Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Congenital Myopathies VCEP
The NM_001164508.2 c.1493A>G (p.Asp498Gly) variant in NEB is a missense variant predicted to cause a substitution of aspartic acid by glycine at amino acid 498. The highest population minor allele frequency in gnomAD v4.1.0 is 0.00005120 (1/19532) alleles) in East Asian population, which is lower than the ClinGen Congenital Myopathies VCEP threshold (≤0.0000559) for PM2_Supporting, meeting this criterion (PM2_Supporting). This variant has previously been observed in probands who have had nemaline bodies on muscle biopsy (PMID:32403337; Invitae internal data SCV000659742.9) (PP4). The variant has previously been reported in trans with pathogenic variants or rare variants of uncertain significance in 4 probands with clinical features of congenital myopathy (PMID: 33333461; Synnovis internal data SCV001468505.1; Invitae internal data SCV000659742.9) (PM3_Strong). In summary, this variant meets the criteria to be classified as likely pathogenic for Nemaline Myopathy for autosomal recessive inheritance based on the ACMG/AMP criteria applied as specified by the ClinGen Congenital Myopathy VCEP: (PM3_Strong, PP4, PM2_Supporting; ClinGen Congenital Myopathies VCEP Specifications version 1.0.0; 3/10/2025).
Met criteria codes
PM3_Strong
PMID: 33333461 observed a case where a patient was found to have this variant with the NM_001271208.1(NEB):c.21076C>T p.Arg7026* variant (ClinVar: Pathogenic/Likely Pathogenic). The same proband may also be observed in PMID: 32403337 where both variants were found along with a similar phenotype and the papers have similar authors. Internal data also found the variant in a homozygous state for a proband. Invitae reported 3 internal patients with nemaline myopathy and muscle weakness who had the variant with a second pathogenic NEB variant.
PP4
In PMID:32403337, the patient observed with the variant was noted to have nemaline bodies on muscle biopsy.
PM2_Supporting
The variant has a minor allele frequency of 0.00001, which is less than the 0.0000559 threshold set for NEB
Not Met criteria codes
PS2
No segregation data is available
PS4
No case-control studies were found and NEB is a recessive gene so PS4 cannot be applied
PS3
Experimental studies were not performed
PS1
No other variants are identified in the same codon
BP5
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP7
This variant is a missense variant
BP2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP4
The REVEL score is 0.182, which is above the 0.15 threshold
BP1
Both missense and truncating variants can be pathogenic in NEB and therefore BP1 cannot be applied
BP3
This variant is a missense variant
PP1
No segregation data available
PP3
The REVEL score is 0.182, which is below the 0.7 threshold
PP2
PP2 does not apply to NEB because missense variants are not constrained.
PM1
There are no hot spots or critical domains in NEB at this time
PM5
No other variants are identified in the same codon
PM4
This variant is a missense variant
PM6
No segregation data is available
BA1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS2
This variant was not observed in a homozygous healthy adult
BS4
No segregation data available
BS3
Experimental studies were not performed
BS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PVS1
This is a missense variant
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.